Dorado, Puerto Rico-New imaging technologies for glaucoma allow physicians an objective, reproducible, and more user-friendly approach to documenting structural damage to the optic nerve head and retinal nerve fiber layer (RNFL). This is particularly important because, in the majority of glaucoma patients, structural damage occurs before standard visual field loss, noted David S. Greenfield, MD.
Frantz EyeCare reports 98% of Light Adjustable Lens patients achieved refractive accuracy within ±0.50 D of target, exceeding published national cataract surgery benchmarks.
In this Q&A, Ping Moore, OD, covers emerging dry eye therapies, from selenium sulfide to next-gen cyclosporine, and how subtype-guided care shapes treatment choices.
Findings from the third annual State of Dry Eye survey link symptom management to quality of life gains, including lower anxiety and improved self-confidence.